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PERSPECTIVE
Fine-tuning of hematopoietic stem cell
homeostasis: novel role for ubiquitin
ligase
Tomomasa Yokomizo and Elaine Dzierzak1
Department of Cell Biology, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands
Homeostasis of hematopoietic stem cells (HSCs) is a
tightly regulated process, controlled by intrinsic and ex-
trinsic signals. Although a variety of molecules involved
in HSC maintenance and self-renewal are known, it re-
mains unclear how robust HSC homeostasis is achieved.
In this issue of Genes & Development, Rathinam and
colleagues (pp. 992–997) report a new player in HSC ho-
meostasis, c-Cbl ubiq-uitin ligase. They show that this
E3 ubiquitin ligase acts as a negative regulator of cyto-
kine signaling.
The E3 ubiquitin ligase c-Cbl is a member of the RING
finger-type ubiquitin ligase Cbl (casitas B-cell lymphoma)
family. It has been shown to interact with several tyrosine
kinase receptors and other adaptor proteins to “fine-
tune” lymphocyte antigen receptor signaling, mainly
through ubiquitination (for review, see Duan et al. 2004).
To study the role of c-Cbl in hematopoietic stem cells
(HSCs), Rathinam et al. (2008) examined mice lacking
c-Cbl. Surprisingly, they observed that the number of
HSCs (CD34−Flt3−LSK or CD150+CD48− cells) was in-
creased in the bone marrow of c-Cbl-deficient mice, and
that c-Cbl-deficient HSCs were more competent than
wild-type HSCs in reconstituting the hematopoietic sys-
tem. Examination of another c-Cbl mutant mouse line,
in which E3 ligase activity was ablated but the tyrosine
kinase-binding domain was preserved, showed an almost
identical HSC phenotype to that of c-Cbl-deficient
HSCs. These results strongly suggest that ubiquitin-me-
diated protein degradation is important for HSC homeo-
stasis.
What is the target substrate for c-Cbl in HSCs?
Rathinam et al. (2008) observed accumulation of signal
transducer and activator of transcription 5 (STAT5) and
phosphorylated STAT5 (activated form) in c-Cbl-defi-
cient HSCs, and proposed that STAT5 is a candidate tar-
get for ubiquitin-mediated degradation. STAT5 is an in-
tracellular transducer of several hematopoietic-specific
cytokine signaling pathways. Therefore, although there are
many targets of c-Cbl (Duan et al. 2004), it is likely that
STAT5 is a major target of c-Cbl in the context of HSC
homeostasis.
HSC homeostasis and cytokine signaling
Many cytokines have been tested for their ability to
stimulate self-renewal and expansion of HSCs in vitro.
Thrombopoietin (TPO) and Stem Cell Factor (SCF) are rec-
ognized as important positive regulators of HSC self-re-
newal and expansion, although expansion has not been
achieved thus far. The receptors for TPO and SCF—c-Mpl
and c-Kit, respectively—are expressed on transplantable
HSCs (Ikuta and Weissman 1992; Solar et al. 1998;
Adolfsson et al. 2001; Yoshihara et al. 2007), and mice
with genetic mutations in TPO, SCF, c-Mpl, or c-Kit are
reduced in HSC numbers (Russell 1979; Kimura et al.
1998; Qian et al. 2007). Interestingly, Rathinam et al.
(2008) show that c-Cbl-deficient HSCs are hypersensitive
to TPO. TPO-c-Mpl activates three downstream signaling
pathways: mitogen-activated protein kinase (MAPK) (Roj-
nuckarin et al. 1999), phosphoinositide 3-kinase-Akt
(PI3K-AKT) (Geddis et al. 2001), and Janus kinase (JAK)–
STAT3 and STAT5 (Dorsch et al. 1995; Drachman et al.
1995). Kato et al. (2005) reported that STAT5 activation
was observed in HSCs (CD34−KSL cells) after TPO
stimulation, and overexpression of STAT5 in HSCs en-
hanced their self-renewal activity ex vivo. Thus, it is
likely that JAK–STAT is an important downstream path-
way of TPO signaling for HSC maintenance. Consistent
with this notion, HSCs lacking Lnk, an adaptor protein
functioning as a negative regulator of several cytokine
signaling pathways, show increased self-renewal capac-
ity and an increased amount of phosphorylated STAT5
in the presence of TPO signaling (Ema et al. 2005; Buza-
Vidas et al. 2006; Seita et al. 2007). The phenotypes of
c-Cbl-deficient HSCs resemble those of Lnk-deficient
HSCs, showing both hypersensitivity to TPO and in-
creased phosphorylated STAT5 (Rathinam et al. 2008).
Although it is uncertain whether there is a direct rela-
tionship between Lnk and c-Cbl, Rathinam et al. (2008)
clearly show that c-Cbl modulates the c-Mpl–TPO–JAK–
STAT signaling pathway in HSCs.
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HSC maintenance in the bone marrow niche
HSC self-renewal and differentiation are thought to be
controlled through interactions with the bone marrow
niche (for review, see Wilson and Trumpp 2006). In the
bone marrow, HSCs are associated with osteoblasts, en-
dothelial cells, or CXCL12+ reticular cells (Calvi et al.
2003; Zhang et al. 2003; Kiel et al. 2005; Sugiyama et al.
2006). Although it is still unclear why several distinct
niches exist in the bone marrow, various molecules have
been proposed to be involved in the signaling between
HSCs and the niche (Wilson and Trumpp 2006). Among
them, Angiopoietin-1, a ligand for the Tie-2 receptor, is
expressed by osteoblasts in the bone marrow niche and is
important for maintaining HSC quiescence (Arai et al.
2004). Notch signaling also has been proposed to be cru-
cial for HSC expansion in the niche, since Notch1 and
Jagged1 are expressed by HSCs and osteoblasts, respec-
tively (Calvi et al. 2003), and inhibition of Notch signal-
ing by a dominant-negative protein results in accelerated
differentiation of HSCs in vitro and depletion of HSCs in
vivo (Duncan et al. 2005). However, conditional deletion
studies reveal that these molecules are dispensable for
HSC maintenance in vivo (Mancini et al. 2005).
Until recently, it was unclear whether TPO signaling
is involved in HSC maintenance within the bone mar-
row niche. However, Yoshihara et al. (2007) and Qian et
al. (2007) reported that TPO is expressed by osteoblasts
in the bone marrow niche and is involved in HSC qui-
escence and expansion. Given that c-Cbl-deficient mice
have increased numbers of HSCs in the bone marrow and
c-Cbl-deficient HSCs are hypersensitive to TPO
(Rathinam et al. 2008), it is plausible that c-Cbl modu-
lates the signal from TPO-producing osteoblasts in the
bone marrow niche through the ubiquitination of
STAT5. Of note, the JAK–STAT signaling pathway is
also involved in blood cell homeostasis in Drosophila.
Like the mouse bone marrow niche, a small cluster of
cells in the primary lobe of the Drosophila lymph
gland—termed the posterior signaling center—controls
the balance between multipotent prohemocytes and dif-
ferentiating hemocytes. In STAT mutant flies, increased
hemocyte differentiation has been observed (Krzemien et
al. 2007), implicating JAK–STAT signaling in the main-
tenance of undifferentiated hemocyte progenitors. Thus,
the JAK–STAT signaling pathway may be evolutionally
conserved in function, providing maintenance of stem
cells within the niche.
While accumulating evidence indicates that interac-
tion between stem cells and a niche is critical for stem
cell maintenance, two recent studies have demonstrated
that there is a competition between stem cells for niche
occupancy. Jin et al. (2008) demonstrated that in Dro-
sophila, bgcn and bam mutant germline stem cells (GSCs)
push wild-type GSCs out of the niche because of their
higher expression of E-cadherin. Similar stem cell com-
petition has been observed in the mouse bone marrow
niche. Czechowicz et al. (2008) showed that treatment
with ACK2, an antibody that blocks c-Kit function,
cleared host HSCs from the niche and enabled HSC en-
graftment without irradiation. In addition, the number
of HSCs in the bone marrow has been shown to correlate
with the number of osteoblasts (Calvi et al. 2003). These
results strongly suggest that the number of niches is lim-
ited. If so, where within the bone marrow environment
are the surplus HSCs in c-Cbl-deficient mice localized?
Or, in the steady-state bone marrow, are the niches not
fully occupied by HSCs? One possibility is that c-Cbl-
deficient HSCs have a greater adhesive ability for the
niches than wild-type HSCs and associate with “incom-
plete niches,” thus resulting in higher numbers of HSCs
in the bone marrow. Consistently, Rathinam et al. (2008)
observe that c-Cbl-deficient HSCs are more competent
than wild-type HSCs in bone marrow reconstitution.
Further detailed and quantitative histological analysis of
the bone marrow of c-Cbl-deficient mice may answer
this question.
Outside the bone marrow: HSC homeostasis
in embryos
During embryonic stages, HSCs are generated prior to
the establishment of the bone marrow niches. It is still
unclear whether the embryonic niches that maintain
HSCs are equivalent to adult bone marrow niches. Stro-
mal cell lines isolated from several embryonic HSC
niches (aorta–gonad–mesonephros region and liver) have
been shown to support the maintenance of adult bone
marrow HSCs (Oostendorp et al. 2005; Durand et al.
2007). However, other studies indicate that the proper-
ties of HSCs differ between embryonic and adult stages,
although it seems that they share the same embryonic
origin (Göthert et al. 2005; Samokhvalov et al. 2007).
HSCs change from a rapidly proliferating state to a
quiescent state between 3 and 4 wk after birth (Bowie et
al. 2006). Moreover, conditional depletion of the Sox17
transcription factor revealed that it is required for the
maintenance of fetal and neonatal HSCs, but not adult
HSCs (Kim et al. 2007). In contrast, Tie receptors are
important for regulation of adult HSCs, but not fetal
HSCs (Puri and Bernstein 2003). Sensitivity to cytokines
is also different between HSCs from embryonic and
adult stages. Fetal HSCs are more sensitive to SCF than
adult HSCs despite the same expression level of c-Kit
(Bowie et al. 2007). In addition, TPO is crucial for expan-
sion of adult HSCs, but not fetal HSCs (Qian et al. 2007).
To date, it is unknown what factors modulate the sen-
sitivity to these cytokines. It is now worth considering
the possibility that protein modifications like ubiquiti-
nation affect the sensitivity of HSCs to cytokines.
Does aberrant control of ubiquitination lead
to leukemia?
It has been well documented that regulators of HSC
maintenance are also involved in leukemic induction
(for review, see Rizo et al. 2006). Although Rathinam et
al. (2008) have not observed tumor formation in c-Cbl-
HSC homeostasis and ubiquitination
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deficient mice, it is possible that accumulation of
STAT5 in c-Cbl-deficient HSCs increases susceptibility
for leukemic transformation, since overexpression of
STAT5 in HSCs induces myeloproliferative disease
(Kato et al. 2005). In this regard, the study by Rathinam
et al. (2008) might be extrapolated to other molecules
like PTEN, TEL, and Gfi1, which have been reported to
be involved in both HSC homeostasis and leukemia
(Akagi et al. 2004; Hock et al. 2004a,b; Yilmaz et al.
2006; O’Neil and Look 2007). These proteins are also
ubiquitinated (Chakrabarti et al. 1999; Marteijn et al.
2007; Trotman et al. 2007; Wang et al. 2007). Thus, dys-
regulation of ubiquitin-mediated degradation may result
in HSC exhaustion or tumor formation. Indeed, it has
been reported that the PTEN protein level controlled by
NEDD4-1 ubiquitin ligase influences its tumor suppres-
sor activity (Trotman et al. 2007; Wang et al. 2007).
The study by Rathinam et al. (2008) now opens a new
avenue for understanding the regulation of intracellular
signaling and a further mechanism underlying HSC ho-
meostasis. While researchers have looked previously to
surface signaling molecules on HSCs to prospectively iso-
late and characterize HSCs, we should now begin to focus
on the fine-tuning of intracellular signaling molecules by
ubiquitination events inside HSCs. With the improvement
of detection methods, it will be important to demonstrate
the direct targets of ubiquitination in HSCs.
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